Stay updated on Avelumab in Combination with CRT Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Combination with CRT Clinical Trial page.

Latest updates to the Avelumab in Combination with CRT Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAn NIH notice about the terminology transition appears above the ClinicalTrials.gov page, whose study content remains inaccessible behind a 403 Forbidden error. The site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now renders a 403 Forbidden error with a minimal header and a Home button, replacing the full study record content and navigation. This indicates the page is currently inaccessible.SummaryDifference17%

- Check48 days agoChange DetectedThe page shows Revision: v3.7.0 (and removal of v3.6.6), indicating a new release. This is a backend/content management update rather than a modification to the study details or results.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page's revision label changed from v3.6.5 to v3.6.6, indicating a site update that does not alter the displayed study information or user workflow.SummaryDifference0.0%

- Check69 days agoChange DetectedAn extra line under Other Identifiers shows '2016 ( U.S. NIH Grant/Contract )'. This adds an NIH funding reference to the study's identifiers.SummaryDifference0.0%

Stay in the know with updates to Avelumab in Combination with CRT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Combination with CRT Clinical Trial page.